Argus Cognitive Receives FDA Clearance for 3D Echocardiographic Right Ventricular Analysis Tool
Software medical device developer Argus Cognitive has announced its ReVISION platform has received (510k) FDA clearance. ReVISION allows medical professionals to better diagnose and stratify right ventricular dysfunction in patients with cardiopulmonary diseases, according to the August 15 company statement.
Source: dicardiology.com